307 related articles for article (PubMed ID: 26043758)
1. Identification of epigenetic modifications that contribute to pathogenesis in therapy-related AML: Effective integration of genome-wide histone modification with transcriptional profiles.
Yang XH; Wang B; Cunningham JM
BMC Med Genomics; 2015; 8 Suppl 2(Suppl 2):S6. PubMed ID: 26043758
[TBL] [Abstract][Full Text] [Related]
2. Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells.
Nishioka C; Ikezoe T; Yang J; Yokoyama A
PLoS One; 2015; 10(5):e0125017. PubMed ID: 25955299
[TBL] [Abstract][Full Text] [Related]
3. Histone post-translational modifications associated to BAALC expression in leukemic cells.
Franzoni A; Passon N; Fabbro D; Tiribelli M; Damiani D; Damante G
Biochem Biophys Res Commun; 2012 Jan; 417(2):721-5. PubMed ID: 22197554
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability.
Salzberg AC; Harris-Becker A; Popova EY; Keasey N; Loughran TP; Claxton DF; Grigoryev SA
PLoS One; 2017; 12(3):e0173723. PubMed ID: 28301528
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic mechanisms in AML - a target for therapy.
Oki Y; Issa JP
Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
[TBL] [Abstract][Full Text] [Related]
6. Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia.
Göllner S; Oellerich T; Agrawal-Singh S; Schenk T; Klein HU; Rohde C; Pabst C; Sauer T; Lerdrup M; Tavor S; Stölzel F; Herold S; Ehninger G; Köhler G; Pan KT; Urlaub H; Serve H; Dugas M; Spiekermann K; Vick B; Jeremias I; Berdel WE; Hansen K; Zelent A; Wickenhauser C; Müller LP; Thiede C; Müller-Tidow C
Nat Med; 2017 Jan; 23(1):69-78. PubMed ID: 27941792
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of E-cadherin gene induced by lncRNA MALAT-1 in acute myeloid leukaemia.
Huang J; Fang J; Chen Q; Chen J; Shen J
J Clin Lab Anal; 2022 Aug; 36(8):e24556. PubMed ID: 35747989
[TBL] [Abstract][Full Text] [Related]
8. Stability of histone modifications across mammalian genomes: implications for 'epigenetic' marking.
Lee BM; Mahadevan LC
J Cell Biochem; 2009 Sep; 108(1):22-34. PubMed ID: 19623574
[TBL] [Abstract][Full Text] [Related]
9. A distinct epigenetic signature at targets of a leukemia protein.
Rossetti S; Hoogeveen AT; Liang P; Stanciu C; van der Spek P; Sacchi N
BMC Genomics; 2007 Feb; 8():38. PubMed ID: 17266773
[TBL] [Abstract][Full Text] [Related]
10. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts.
Gozzini A; Santini V
Ann Hematol; 2005 Dec; 84 Suppl 1():54-60. PubMed ID: 16228241
[TBL] [Abstract][Full Text] [Related]
11. miR-155 regulative network in FLT3 mutated acute myeloid leukemia.
Salemi D; Cammarata G; Agueli C; Augugliaro L; Corrado C; Bica MG; Raimondo S; Marfia A; Randazzo V; Dragotto P; Di Raimondo F; Alessandro R; Fabbiano F; Santoro A
Leuk Res; 2015 Aug; 39(8):883-96. PubMed ID: 26055960
[TBL] [Abstract][Full Text] [Related]
12. Integrated genomics of susceptibility to alkylator-induced leukemia in mice.
Cahan P; Graubert TA
BMC Genomics; 2010 Nov; 11():638. PubMed ID: 21080971
[TBL] [Abstract][Full Text] [Related]
13. Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia.
van Dijk AD; Hoff FW; Qiu YH; Chandra J; Jabbour E; de Bont ESJM; Horton TM; Kornblau SM
Clin Epigenetics; 2021 Jan; 13(1):21. PubMed ID: 33509276
[TBL] [Abstract][Full Text] [Related]
14. Expression profile of CREB knockdown in myeloid leukemia cells.
Pellegrini M; Cheng JC; Voutila J; Judelson D; Taylor J; Nelson SF; Sakamoto KM
BMC Cancer; 2008 Sep; 8():264. PubMed ID: 18801183
[TBL] [Abstract][Full Text] [Related]
15. A non-viral nano-delivery system targeting epigenetic methyltransferase EZH2 for precise acute myeloid leukemia therapy.
Kaundal B; Kushwaha AC; Srivastava AK; Karmakar S; Choudhury SR
J Mater Chem B; 2020 Sep; 8(37):8658-8670. PubMed ID: 32844866
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide mapping of histone H3 lysine 4 trimethylation in Eucalyptus grandis developing xylem.
Hussey SG; Mizrachi E; Groover A; Berger DK; Myburg AA
BMC Plant Biol; 2015 May; 15():117. PubMed ID: 25957781
[TBL] [Abstract][Full Text] [Related]
17. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.
Scott SA; Dong WF; Ichinohasama R; Hirsch C; Sheridan D; Sanche SE; Geyer CR; Decoteau JF
Leuk Res; 2006 Jan; 30(1):69-76. PubMed ID: 16043219
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomic analysis of EZH2 inhibition in acute myeloid leukemia reveals the targets and pathways that precede the induction of cell death.
Sandow JJ; Infusini G; Holik AZ; Brumatti G; Averink TV; Ekert PG; Webb AI
Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28447382
[TBL] [Abstract][Full Text] [Related]
19. MYC amplification in multiple marker chromosomes and EZH2 microdeletion in a man with acute myeloid leukemia.
Xiang Z; Abdallah AO; Govindarajan R; Mehta P; Emanuel PD; Papenhausen P; Schichman SA
Cancer Genet; 2015 Mar; 208(3):96-100. PubMed ID: 25800664
[TBL] [Abstract][Full Text] [Related]
20. Epigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells.
Spencer DH; Young MA; Lamprecht TL; Helton NM; Fulton R; O'Laughlin M; Fronick C; Magrini V; Demeter RT; Miller CA; Klco JM; Wilson RK; Ley TJ
Leukemia; 2015 Jun; 29(6):1279-89. PubMed ID: 25600023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]